The role of the orthopaedic surgeon in minimizing mortality and morbidity associated with fragility fractures

Journal of the American Academy of Orthopaedic Surgeons

Volumn 18, Issue 5, 2010, Pages 278-285

  Ekman, Evan F ^a  

^a Southern Orthopaedic Sports Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77952386221     PISSN: 1067151X     EISSN: None     Source Type: Journal    
DOI: 10.5435/00124635-201005000-00004     Document Type: Review

References (39)

1. National Osteoporosis Foundation: Clinician's Guide to the Prevention and Treatment of Osteoporosis, 2008. Available at: http://www.nof.org/ professionals/cliniciansguide-form.asp. Accessed December 29, 2009.
2. Hallberg I, Rosenqvist AM, Kartous L, Löfman O, Wahlström O, Toss G: Health-related quality of life after osteoporotic fractures. Osteoporos lnt 2004;15:834-841.
3. Dharmarajan TS, Banik P: Hip fracture: Risk factors, preoperative assessment, and postoperative management. Postgrad Med 2006;119:31-38.
4. Paksima N, Koval KJ, Aharanoff G, et al: Predictors of mortality after hip fracture: A 10-year prospective study. Bull NYU Hosp Jt Dis 2008;66:111-117.
5. von Friesendorff M, Besjakov J, Akesson K: Long-term survival and fracture risk after hip fracture: A 22-year follow-up in women. J Bone Miner Res 2008;23: 1832-1841.
6. Novack V, Jotkowitz A, Etzion O, Porath A: Does delay in surgery after hip fracture lead to worse outcomes? A multicenter survey. Int J Qual Health Care 2007;19:170-176.
7. US Department of Health and Human Services: Bone Health and Osteoporosis: A Report of the Surgeon General. Rockville, MD, US Department of Health and Human Services, Office of the Surgeon General, 2004.
8. Melton LJ III: Adverse outcomes of osteoporotic fractures in the general population. J Bone Miner Res 2003;18:1139-1141.
9. Lyles KW, Schenck AP, Colón-Emeric CS: Hip and other osteoporotic fractures increase the risk of subsequent fractures in nursing home residents. Osteoporos Int 2008;19:1225-1233.
10. Lyles KW, Colón-Emeric CS, Magaziner JS, et al: Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med 2007;357:1799-1809.
11. Petrella RJ, Jones TJ: Do patients receive recommended treatment of osteoporosis following hip fracture in primary care? BMC Earn Pract 2006;7:31.
12. Solomon DH, Finkelstein JS, Katz JN, Mogun H, Avorn J: Underuse of osteoporosis medications in elderly patients with fractures. Am J Med 2003;115:398-400.
13. World Health Organization: Prevention and Management of Osteoporosis: Report of a WHO Scientific Group. WHO Technical Report Series 921. Geneva, Switzerland, World Health Organization, 2003.
14. Dawson-Hughes B, Tosteson AN, Melton LJ III, et al: Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA. Osteoporos Int 2008; 19:449-458.
15. FRAX®WHO Fracture Risk Assessment Tool. World Health Organization Collaborating Centre for Metabolic Bone Diseases, University of Sheffield, UK. Available at: http://www.shef.ac.uk/ FRAX. Accessed February 23, 2010.
16. Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E: FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int 2008;19:385-397.
17. Holick MF, Matsuoka LY, Wortsman J: Age, vitamin D, and solar ultraviolet. Lancet 1989;2:1104-1105.
18. Rizzoli R, Boonen S, Brandi ML, Burlet N, Delmas P, Reginster JY: The role of calcium and vitamin D in the management of osteoporosis. Bone 2008;42: 246-249.
19. Nordin BE, Need AG, Morris HA, O'Loughlin PD, Horowitz M: Effect of age on calcium absorption in postmenopausal women. Am J Clin Nutr 2004;80: 998-1002.
20. National Institutes of Health, Office of Dietary Supplements: Dietary Supplement Fact Sheet: Calcium. Bethesda, MD, 2009. Available at: http:// dietary-supplements.info.nih.gov/ factsheets/calcium.asp. Accessed December 29, 2009.
21. Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board, Institute of Medicine: Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D and Fluoride. Washington, DC, National Academy Press, 1997.
22. Rao SS, Cherukuri M: Management of hip fracture: The family physician's role. Am Fam Physician 2006;73:2195-2200.
23. Actonel (risedronate sodium tablets) Product Information. Procter & Gamble Pharmaceuticals, Incorporated, Cincinnati, OH, 2007.
24. Reclast (zoledronic acid) Injection Product Information. Novartis Pharmaceuticals Corporation, East Hanover, NJ, 2008.
25. Forteo (teriparatide [rDNA origin] Injection) Product Information. Eli Lilly and Company, Indianapolis, IN, 2008.
26. Kimmel DB: Mechanism of action, pharmacokinetic and pharmacodynamic profile, and clinical applications of nitrogencontaining bisphosphonates. J Dent Res 2007;86:1022-1033.
27. Chapurlat RD, Delmas PD: Drug insight: Bisphosphonates for postmenopausal osteoporosis. Nat Clin Pract Endocrinol Metab 2006;2:211-219.
28. Fosamax (alendronate sodium) Tablets and Oral Solution Product Information. Merck & Co, Inc, Whitehouse Station, NJ, 2007.
29. Rabenda V, Mertens R, Fabri V, et al: Adherence to bisphosphonates therapy and hip fracture risk in osteoporotic women. Osteoporos Int 2008;19:811-818.
30. Boniva (ibandronate sodium) Tablets Product Information. Roche Laboratories, Nutley, NJ, 2007. Available at: http://www.gene.com/gene/products/ information/boniva/pdf/Injection-pi.pdf. Accessed February 24, 2010.
31. Eisman JA, Civitelli R, Adami S, et al: Efficacy and tolerability of intravenous ibandronate injections in postmenopausal osteoporosis: 2-year results from the DIVA study. J Rheumatol 2008;35: 488-497.
32. Black DM, Delmas PD, Eastell R, et al: Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med 2007;356:1809-1822.
33. Boniva (ibandronate sodium) Tablets Product Information. Roche Laboratories, Nutley, NJ, 2006.
34. Felsenberg D, Hoffmeister B, Amling M, Mundlos S, Seibel M, Fratzl P: Onkologie: Kiefernekrosen nach hoch dosierter Bisphophonattherapie. Dtsch Arztebl 2006;103:3078-3081.
35. American Dental Association: Osteonecrosis of the Jaw. Available at: http://www.ada.org/public/topics/ osteonecrosis.asp. Accessed December 29, 2009.
36. Gardner MJ, Brophy RH, Demetrakopoulos D, et al: Interventions to improve osteoporosis treatment following hip fracture: A prospective, randomized trial. J Bone Joint Surg Am 2005;87:3-7.
37. Morrison RS, Magaziner J, McLaughlin MA, et al: The impact of post-operative pain on outcomes following hip fracture. Pain 2003;103:303-311.
38. Ekman EF, Koman LA: Acute pain management following musculoskeletal injuries and orthopaedic surgery: Mechanisms and management. Inst Course Lect 2005;54:21-33.
39. Gerstenfeld LC, Thiede M, Seibert K, et al: Differential inhibition of fracture healing by non-selective and cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs. J Orthop Res 2003;21:670-675.